EPFL
By
EPFL
Published: May 3, 2017, 5:25 p.m.·
Tags:
Medicines,
Scientific research
21.04.17 - The Bill & Melinda Gates foundation has awarded EPFL-based non-profit iM4TB $2.45 million to take their innovative anti-tuberculosis drug PBTZ169 into clinical trials.
Read More →
By
EPFL
Published: July 8, 2015, 10:01 p.m.·
Tags:
Medicines
07.07.15 - Testing thousands of approved drugs, EPFL scientists have identified an unlikely anti-tuberculosis drug: the over-the-counter antacid lansoprazole (Prevacid®).
Read More →
By
EPFL
Published: March 12, 2014, 9:03 p.m.·
Tags:
Drug-resistant TB
12.03.14 - Even though tuberculosis kills more than 1.5 million people every year, the market is not cost-effective for pharmaceutical companies. So EPFL is setting up a foundation to release an antibiotic developed in its own laboratories under EU funding.
Read More →
Page 1 of 1 · Total posts: 3
1